HK1148749A1 - Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid - Google Patents

Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid

Info

Publication number
HK1148749A1
HK1148749A1 HK11103104.4A HK11103104A HK1148749A1 HK 1148749 A1 HK1148749 A1 HK 1148749A1 HK 11103104 A HK11103104 A HK 11103104A HK 1148749 A1 HK1148749 A1 HK 1148749A1
Authority
HK
Hong Kong
Prior art keywords
dimethoxy
octa
bicyclo
tetrahydro
azepin
Prior art date
Application number
HK11103104.4A
Other languages
English (en)
Inventor
Jean-Louis Peglion
Aimee Dessinges
Bernard Serkiz
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40983371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1148749(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1148749A1 publication Critical patent/HK1148749A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HK11103104.4A 2009-03-31 2011-03-28 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid HK1148749A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901556A FR2943668B1 (fr) 2009-03-31 2009-03-31 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.

Publications (1)

Publication Number Publication Date
HK1148749A1 true HK1148749A1 (en) 2011-09-16

Family

ID=40983371

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11103104.4A HK1148749A1 (en) 2009-03-31 2011-03-28 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid

Country Status (35)

Country Link
US (1) US8119794B2 (ar)
EP (1) EP2241553B1 (ar)
JP (1) JP5107381B2 (ar)
KR (1) KR101166632B1 (ar)
CN (1) CN101851204B (ar)
AR (1) AR075978A1 (ar)
AT (1) ATE517093T1 (ar)
AU (1) AU2010201035B2 (ar)
BR (1) BRPI1000865A2 (ar)
CA (1) CA2697563C (ar)
CL (1) CL2010000253A1 (ar)
CY (1) CY1111914T1 (ar)
DK (1) DK2241553T3 (ar)
EA (1) EA016353B1 (ar)
ES (1) ES2370150T3 (ar)
FR (1) FR2943668B1 (ar)
GE (1) GEP20125446B (ar)
HK (1) HK1148749A1 (ar)
HR (1) HRP20110683T1 (ar)
JO (1) JO2781B1 (ar)
MA (1) MA31746B1 (ar)
ME (1) ME00986B (ar)
MX (1) MX2010003213A (ar)
MY (1) MY150014A (ar)
NZ (1) NZ584310A (ar)
PE (1) PE20110098A1 (ar)
PL (1) PL2241553T3 (ar)
RS (1) RS51920B (ar)
SA (1) SA110310239B1 (ar)
SI (1) SI2241553T1 (ar)
TW (1) TWI376371B (ar)
UA (1) UA105894C2 (ar)
UY (1) UY32499A (ar)
WO (1) WO2010112705A1 (ar)
ZA (1) ZA201002120B (ar)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2471780E (pt) * 2007-05-30 2015-02-24 Ind Swift Lab Ltd Sais oxalato de ivabradina cristalinos e seus polimorfos
FR2971507B1 (fr) * 2011-02-14 2013-01-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
CN103848789B (zh) * 2012-11-29 2016-05-18 江苏恒瑞医药股份有限公司 一种伊伐布雷定的制备方法
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN113372273B (zh) * 2020-03-10 2023-05-09 鲁南制药集团股份有限公司 一种伊伐布雷定中间体化合物iv
CN113372274B (zh) * 2020-03-10 2023-03-24 鲁南制药集团股份有限公司 一种伊伐布雷定的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
PT2471780E (pt) 2007-05-30 2015-02-24 Ind Swift Lab Ltd Sais oxalato de ivabradina cristalinos e seus polimorfos

Also Published As

Publication number Publication date
AU2010201035A1 (en) 2010-10-14
TWI376371B (en) 2012-11-11
MX2010003213A (es) 2010-10-05
CA2697563A1 (fr) 2010-09-30
HRP20110683T1 (hr) 2011-10-31
FR2943668A1 (fr) 2010-10-01
US20100249398A1 (en) 2010-09-30
MA31746B1 (ar) 2010-10-01
TW201041854A (en) 2010-12-01
UA105894C2 (uk) 2014-07-10
FR2943668B1 (fr) 2011-05-06
KR101166632B1 (ko) 2012-07-19
AU2010201035B2 (en) 2015-03-19
ZA201002120B (en) 2010-11-24
AR075978A1 (es) 2011-05-11
EA016353B1 (ru) 2012-04-30
WO2010112705A1 (fr) 2010-10-07
JO2781B1 (ar) 2014-03-15
ATE517093T1 (de) 2011-08-15
PE20110098A1 (es) 2011-03-02
EP2241553A1 (fr) 2010-10-20
EA201000398A1 (ru) 2010-12-30
DK2241553T3 (da) 2011-10-31
ME00986B (me) 2012-06-20
SA110310239B1 (ar) 2014-03-02
PL2241553T3 (pl) 2011-11-30
MY150014A (en) 2013-11-15
ES2370150T3 (es) 2011-12-13
BRPI1000865A2 (pt) 2012-01-17
CN101851204B (zh) 2013-02-13
CN101851204A (zh) 2010-10-06
CY1111914T1 (el) 2015-11-04
UY32499A (es) 2010-09-30
RS51920B (en) 2012-02-29
GEP20125446B (en) 2012-03-26
JP5107381B2 (ja) 2012-12-26
US8119794B2 (en) 2012-02-21
EP2241553B1 (fr) 2011-07-20
SI2241553T1 (sl) 2011-10-28
JP2010241808A (ja) 2010-10-28
CL2010000253A1 (es) 2011-04-25
CA2697563C (fr) 2012-05-15
NZ584310A (en) 2010-11-26
KR20100109527A (ko) 2010-10-08

Similar Documents

Publication Publication Date Title
HK1148749A1 (en) Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MXPA05003694A (es) Nuevo proceso para la sintesis ivabradina y sales de adicion de la misma con un acido farmaceuticamente aceptable.
WO2008065681A3 (en) Process for preparation of ivabradine hydrochloride
US6982350B2 (en) Process for the synthesis of (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
US8097720B2 (en) Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
HK1148748A1 (en) Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
NZ593437A (en) Use of the association of ivabradine and perindopril in the treatment of heart failure
GEP20074136B (en) New process for the synthesis of 1,3,4,5-tetrahydro-2h-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
US20130211070A1 (en) New process for the resolution of enantiomers of (3,4 dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)nitrile and application in the synthesis of ivabradine
AU2010210054A1 (en) Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof
CO5790168A1 (es) Nueva asociacion de un inhibidor de la corriente sinusual if y de un inhibidor de la enzima de conversion y las composiciones farmaceuticas que la contienen
AR058575A1 (es) Asociacion de un inhibidor de la corriente sinusal if y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
SG144832A1 (en) Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
US9045788B2 (en) Process for the enzymatic synthesis of (7S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl) N-methyl methanamine, and application in the synthesis of ivabradine and salts thereof
SG116573A1 (en) New process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds, and application in thesynthesis of ivabradine and addition salts thereofwith a pharmaceutically acceptable acid.
CN201640525U (zh) 一种有氧口罩
AR070416A1 (es) Asociacion de un inhibidor de corriente sinusal if y de un beta-bloqueante
US8859763B1 (en) Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]OCTA-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MD20130016A2 (en) New process for the synthesis of ivabradine and addition salts thereof with pharmaceutically acceptable acids
NZ622915A (en) Process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine
TW200700386A (en) Process for the preparation of racemic and optically active 4-chloro-3-[5-chloro-1-(2,4-dimethoxybenzyl)-3-alkyl-2-oxo-2,3-dihydro-1h-indol-3-yl]benzoic acid derivatives
CL2008003569A1 (es) Proceso de sintesis de ivabradina y sus sales de adicion de acido farmaceuticamente aceptable (divisional de la solicitud 318-05).

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200327